Ameriprise
ZURA icon

Ameriprise’s Zura Bio ZURA Stock Holding History

Ameriprise’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Hold
282,207
– – ﹤0.01% 3179
2026
Q1 		$1.68M Buy
+282,207
New +$1.7M ﹤0.01% 3036
2025
Q4 		– Sell
-500,000
Closed -$2.17M – 4233
2025
Q3 		$2.17M Buy
+500,000
New +$899K ﹤0.01% 2963

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Ameriprise's ZURA Position: Q2 2026 in Review

Ameriprise held its Zura Bio (ZURA) position steady in Q2 2026 at 282,207 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3179.

Ameriprise first reported a position in ZURA in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.17M in Q3 2025. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Ameriprise held 282,207 shares of Zura Bio worth $1.67M as of Q2 2026.
  • Ameriprise left its Zura Bio share count unchanged in Q2 2026.
  • Zura Bio made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3179 holding.
  • Ameriprise first reported a position in Zura Bio in Q3 2025 and has held it in 3 quarters since.
  • Ameriprise's Zura Bio position peaked at $2.17M in Q3 2025.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.